Background: The mesolimbic system plays a crucial role in weight regulation and cognition. Previous studies suggest that the pathology of Alzheimer's disease (AD) can lead to the atrophy of the mesolimbic system and body mass index (BMI) decline. It remains unknown whether BMI is associated with the the mesolimbic system in AD.
Method: The data used in this study was obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. All participants underwent at least one Aβ PET imaging. PET imaging was carried out concurrently with brain MRI data and comprehensive neuropsychological assessments. Follow-up data were collected at 2, 4, and 6 years. Hippocampus, amygdala, accumbens, caudate, and putamen were selected as regions of interest (ROIs) in the mesolimbic system. Linear regression was conducted to assess the relationship between BMI and cognition, and the volume of the ROIs. Linear mixed-effects models were employed for longitudinal data analysis.
Result: A total of 1182 participants were included in this study, including 608 cases of Aβ positive and 574 cases of Aβ negative. (1) Compared with the Aβ negative group, the Aβ positive group exhibited a decreased volume of hippocampus, amygdala, accumbens, and putamen and lower BMI (P < 0.01); (2) BMI was associated with baseline hippocampal volume (β = 0.12, P < 0.001), amygdala volume (β = 0.12, P < 0.001), accumbens volume (β = 0.07, P = 0.046), caudate volume (β = 0.09, P = 0.021), and putamen volume (β = 0.09, P = 0.023) in Aβ positive group, whereas, in the Aβ negative group, BMI was not associated with the volume of ROIs; (3) BMI was associated with baseline Mini-Mental State Examination (MMSE) z-score (β = 0.09, P = 0.002) and memory composite score (β = 0.07, P = 0.015), whereas, in the Aβ negative group, BMI was not associated with cognition; (4) longitudinal data analyses involving Aβ positive participants indicated that BMI was associated with the volume of hippocampus, amygdala, accumbens, putamen, MMSE z-score, and memory score.
Conclusion: A lower BMI was associated with smaller volume of mesolimbic system and poorer cognition in AD patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/alz.084088 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Risk Factors for Anastomotic Leakage: A Comprehensive Single-Center Analysis of Colorectal Anastomoses for Ovarian and Gastrointestinal Cancers.
Ann Surg Oncol
January 2025
Department Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Background: Anastomotic leakage (AL) is a major complication in colorectal surgery, particularly following rectal cancer surgery, necessitating effective prevention strategies. The increasing frequency of colorectal resections and anastomoses during cytoreductive surgery (CRS) for peritoneal carcinomatosis further complicates this issue owing to the diverse patient populations with varied tumor distributions and surgical complexities. This study aims to assess and compare AL incidence and associated risk factors across conventional colorectal cancer surgery (CRC), gastrointestinal CRS (GI-CRS), and ovarian CRS (OC-CRS), with a secondary focus on evaluating the role of protective ostomies.
View Article and Find Full Text PDFNovel model of the region of interest modified Mayo Adhesive Probability score.
World J Urol
January 2025
Department of Urology, National Cancer Center Hospital East, Chiba, Japan.
Purpose: To evaluate the association between the newly developed region of interest (ROI)-modified Mayo Adhesive Probability (MAP) score, in which stranding was re-evaluated by computed tomography (CT) number, for predicting operation time in robot-assisted partial nephrectomy (RAPN).
Methods: The study participants were 119 patients who underwent transperitoneal RAPN. With regard to stranding, ROIs were evaluated, and the mean CT numbers were assigned a score ranging from 0 to 3.
Short-Term Assessment of High-Sensitivity C-Reactive Protein (hs-CRP) Changes Following One Anastomosis Gastric Bypass (OAGB) in Patients with Obesity: A Prospective Cohort Study.
Obes Surg
January 2025
Department of Surgery, Minimally Invasive Surgery Research Center, Division of Minimally Invasive and Bariatric Surgery, School of Medicine, Rasool‑E Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Background: Obesity, characterized by excessive adipose tissue, is associated with chronic low-grade inflammation and elevated inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP). This inflammation is linked to obesity-associated medical problems, including cardiovascular diseases. One anastomosis gastric bypass (OAGB) has emerged as an effective metabolic and bariatric surgical procedure to address severe obesity and its associated inflammatory state.
View Article and Find Full Text PDFA systematic review and meta-analysis of exercise-based intervention to prevent gestational diabetes in women with overweight or obesity.
BMC Pregnancy Childbirth
January 2025
Department of Gynecology and Obstetrics, Reina Sofía Hospital, Tudela, Spain.
Background: There is evidence that exercise may reduce the risk of gestational diabetes mellitus (GDM) and improve other obstetric outcomes in overweight or obese pregnant women. However, the available evidence is of low quality and inconclusive. The purpose of this study is to assess the effects of exercise, compared with usual care, in reducing GDM and other obstetric risks, in overweight and obese pregnant women.
View Article and Find Full Text PDFSweat chloride reflects CFTR function and correlates with clinical outcomes following CFTR modulator treatment.
J Cyst Fibros
January 2025
Cystic Fibrosis Therapeutics Development Network Coordinating Center, Seattle Children's Hospital, Seattle, WA, USA; Department of Pediatrics, University of Washington, Seattle, WA, USA; Department of Biostatistics, University of Washington, Seattle, WA, USA.
Background: Highly effective CFTR modulators improve CFTR function and lead to dramatic improvements in health outcomes in many people with cystic fibrosis (pwCF). The relationship between measures of CFTR function, such as sweat chloride concentration, and clinical outcomes in pwCF treated with CFTR modulators is poorly defined. We conducted analyses to better understand the relationships between sweat chloride and CFTR function in vitro, and between sweat chloride and clinical outcomes following CFTR modulator treatment.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!